Alister Coleman
Managing Partner @ Folklore Ventures
Sydney, Australia
Alister Coleman is a Series A investor at Folklore Ventures in Sydney focused on Software and Health Care. Alister is the founder and Managing Partner of Folklore. He has 20 years of experience as an investor, startup founder, adviser and director of technology companies.
- Total investments:
- 14
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Alister Coleman invests in
SoftwareHealth CareReal EstateAsset ManagementProperty Management
Stages Alister Coleman invests in
Series ASeedSeries BSeries CFunding Round
Countries Alister Coleman invests in
AustraliaUnited StatesNew Zealand
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 4 (29%)
- Health Care 2 (14%)
- Real Estate 2 (14%)
- Asset Management 2 (14%)
- Property Management 2 (14%)
Stage
- Series A 5 (36%)
- Seed 3 (21%)
- Series B 2 (14%)
- Series C 2 (14%)
- Funding Round 1 (7%)
Country
- Australia 4 (29%)
- United States 2 (14%)
- New Zealand 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Visionary Machines
|
Visionary Machines uses non-planar arrays of many low cost cameras to deliver high-fidelity long-range spatial 3D models of a scene in real time. Its vision is to enable machines to see and perceive the world. Using its "mix-and-match" approach, its sensor arrays can be multi spectral and can mix optics (such as long range telephotowith wide angle) to deliver unheralded range & fidelity. Its sensor system is passive, has zero cross interference, has high immunity to transient interference (snow, rain, dust), has accurate depth, trajectory (direction & velocity) and object classification. Its cloud-connect option enhances each sensor using models of the world created in the cloud from many other sensors. Applications being targeted are automotive ADAS, surveillance, targeting, mapping in both civilian and military sectors. | $2.3M / Jul 18, 2025 | |
Auror
|
Auror is the retail crime intelligence platform empowering enterprise retailers to stop crime, for good. They do this by making it easy to report actionable intel, connect the dots on repeat offenders, and distribute actionable intelligence to teams to prevent crime in real time. Auror has offices in Denver (Colorado), Auckland (New Zealand), andMelbourne (Australia) to support its growing retail base, which includes some of the largest retailers in the world. | $48.6M / Series C / Nov 12, 2024 | |
SimConverse
|
SimConverse is a first generative AI in healthcare that holds conversation with natural fluency. | $989.1K / Seed / Mar 08, 2023 | |
|
Visionary Machines
|
Visionary Machines uses non-planar arrays of many low cost cameras to deliver high-fidelity long-range spatial 3D models of a scene in real time. Its vision is to enable machines to see and perceive the world. Using its "mix-and-match" approach, its sensor arrays can be multi spectral and can mix optics (such as long range telephotowith wide angle) to deliver unheralded range & fidelity. Its sensor system is passive, has zero cross interference, has high immunity to transient interference (snow, rain, dust), has accurate depth, trajectory (direction & velocity) and object classification. Its cloud-connect option enhances each sensor using models of the world created in the cloud from many other sensors. Applications being targeted are automotive ADAS, surveillance, targeting, mapping in both civilian and military sectors. | $4.8M / Seed / Dec 02, 2022 | |
HealthMatch
|
HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets. | $6.9M / Series C / Sep 12, 2022 | |
|
Auror
|
Auror is the retail crime intelligence platform empowering enterprise retailers to stop crime, for good. They do this by making it easy to report actionable intel, connect the dots on repeat offenders, and distribute actionable intelligence to teams to prevent crime in real time. Auror has offices in Denver (Colorado), Auckland (New Zealand), andMelbourne (Australia) to support its growing retail base, which includes some of the largest retailers in the world. | $20.4M / Series B / Dec 08, 2021 | |
|
HealthMatch
|
HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets. | $13.3M / Series B / Dec 08, 2020 | |
Swoop Aero
|
Swoop Aero is an Australian drone-powered logistics company founded in 2017 to transform how the world moves by making access to the skies seamless. We integrate drone logistics into the first and last mile of the supply chain to transform its strength and agility. Where we don’t deliver that service ourselves, we provide our technology platformselectively to organisations across the globe to further the reach of our impact. Our goal is to provide a service accessible by 1 billion people in 2030, delivering impact across industries including health, transport, disaster management, and Search and Rescue. | Series A / Mar 30, 2020 | |
|
HealthMatch
|
HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets. | $6M / Series A / Nov 05, 2019 | |
|
Swoop Aero
|
Swoop Aero is an Australian drone-powered logistics company founded in 2017 to transform how the world moves by making access to the skies seamless. We integrate drone logistics into the first and last mile of the supply chain to transform its strength and agility. Where we don’t deliver that service ourselves, we provide our technology platformselectively to organisations across the globe to further the reach of our impact. Our goal is to provide a service accessible by 1 billion people in 2030, delivering impact across industries including health, transport, disaster management, and Search and Rescue. | Venture - Series Unknown / Feb 01, 2019 | |
| See all 14 investments → | |||
Co-Investors
About Folklore Ventures
Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.
Folklore Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Albert Bielinko
Partner
|
|||
|
Alister Coleman
Managing Partner
|
|||
Andrew Larsen
Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
SaaS Investors
114,773 investors
Software Investors
56,294 investors
FinTech Investors
47,630 investors
Health Care Investors
47,147 investors
Proptech Investors
23,110 investors
Real Estate Investors
11,532 investors
SaaS VC Funds
70,511 investors
Software VC Funds
35,944 investors
FinTech VC Funds
31,727 investors
FAQ
What does Alister Coleman invest in?
Alister Coleman invests primarily in Software, Health Care and Real Estate startups, most often at Series A and Seed stage. Most of the 14 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Alister Coleman?
Public channels for Alister Coleman include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Alister Coleman last invest?
The most recent investment recorded for Alister Coleman closed in Jul 2025. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
